Asston Pharmaceuticals Reports H1 FY27 Results and Preferential Allotment
Asston Pharmaceuticals Ltd · Outcome · 12 Nov 2026, 11:30 pm
Asston Pharmaceuticals Reports H1 FY27 Results and Preferential Allotment For the half-year ended 30th Sep'26, Asston Pharmaceuticals reported revenue from operations of ₹1,526.58 lakhs, down 0.98% YoY from ₹1,541.59 lakhs in the half-year ended 30th Sep'25. Net profit contracted 3.20% YoY to ₹327.37 lakhs versus ₹338.21 lakhs. PBT stood at ₹437.33 lakhs compared to ₹337.32 lakhs a year earlier. Basic EPS declined to ₹3.70 from ₹9.35. During the period, the company raised ₹2,771.60 lakhs via a preferential allotment of 24.10 lakh equity shares at ₹115 per share on 5th Sep'26.
Original exchange filing (PDF)
More announcements from Asston Pharmaceuticals Ltd
- Unaudited Financial Results for the Half Year ended 30 September, 2026 with Limited Review Report. · 12 Nov 2026
- Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve the Unaudited Financial .... · 12 Nov 2026
- Change in registered office address · 13 Oct 2026
- Outcome of the Board held on 13th October, 2026. · 13 Oct 2026
- Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/10/2026 ,inter alia, to consider and approve matters as attached · 06 Oct 2026
- Change in Management · 01 Oct 2026
- Appointment of Statutory Auditor of the Company · 01 Oct 2026
- Scrutinizer Report · 01 Oct 2026
